Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rieke

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|March 21, 2022
Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021Tanner E Rothstein, Scott A Cunningham, Rachelle A Rieke, et al.
Theriogenology|December 2, 2000
Development and viability of pig oocytes matured in a protein-free medium containing epidermal growth factorL R Abeydeera, W H Wang, T C Cantley, et al.
Theriogenology|March 29, 2000
Birth of piglets preselected for gender following in vitro fertilization of in vitro matured pig oocytes by X and Y chromosome bearing spermatozoa sorted by high speed flow cytometryL R Abeydeera, L A Johnson, G R Welch, et al.
AIDS (London, England)|July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study GroupJ K Rockstroh, F Bergmann, W Wiesel, et al.
European Journal of Medical Research|July 20, 2004
Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in GermanyMark Oette, R Kaiser, M Däumer, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
Animal Biotechnology|January 26, 2002
Production of nuclear transfer-derived swine that express the enhanced green fluorescent proteinK W Park, H T Cheong, L Lai, et al.
Infection|January 21, 2015
Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohortJ M Kittner, L von Bialy, J Wiltink, et al.
Biology of Reproduction|March 22, 2002
Mosaic gene expression in nuclear transfer-derived embryos and the production of cloned transgenic pigs from ear-derived fibroblastsKwang-Wook Park, Liangxue Lai, Hee-Tae Cheong, et al.
Transgenic Research|November 3, 2006
Production of endothelial nitric oxide synthase (eNOS) over-expressing pigletsY H Hao, H Y Yong, C N Murphy, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|March 21, 2022
Macrolide Resistance in Mycoplasma pneumoniae, Midwestern United States, 2014 to 2021Tanner E Rothstein, Scott A Cunningham, Rachelle A Rieke, et al.
Theriogenology|December 2, 2000
Development and viability of pig oocytes matured in a protein-free medium containing epidermal growth factorL R Abeydeera, W H Wang, T C Cantley, et al.
Theriogenology|March 29, 2000
Birth of piglets preselected for gender following in vitro fertilization of in vitro matured pig oocytes by X and Y chromosome bearing spermatozoa sorted by high speed flow cytometryL R Abeydeera, L A Johnson, G R Welch, et al.
AIDS (London, England)|July 14, 2000
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals. German Ritonavir/Indinavir Study GroupJ K Rockstroh, F Bergmann, W Wiesel, et al.
European Journal of Medical Research|July 20, 2004
Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in GermanyMark Oette, R Kaiser, M Däumer, et al.
HIV Medicine|June 13, 2002
Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapyM Lichterfeld, H D Nischalke, F Bergmann, et al.
Animal Biotechnology|January 26, 2002
Production of nuclear transfer-derived swine that express the enhanced green fluorescent proteinK W Park, H T Cheong, L Lai, et al.
Infection|January 21, 2015
Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohortJ M Kittner, L von Bialy, J Wiltink, et al.
Biology of Reproduction|March 22, 2002
Mosaic gene expression in nuclear transfer-derived embryos and the production of cloned transgenic pigs from ear-derived fibroblastsKwang-Wook Park, Liangxue Lai, Hee-Tae Cheong, et al.
Transgenic Research|November 3, 2006
Production of endothelial nitric oxide synthase (eNOS) over-expressing pigletsY H Hao, H Y Yong, C N Murphy, et al.
Pageof 3